THRIVENT FINANCIAL FOR LUTHERANS - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$2,587
-13.3%
87,819
-4.0%
0.01%
-14.3%
Q2 2023$2,984
-9.6%
91,493
-2.4%
0.01%
-12.5%
Q1 2023$3,300
-25.8%
93,781
-3.4%
0.01%
-33.3%
Q4 2022$4,448
-99.9%
97,068
-0.3%
0.01%
-7.7%
Q3 2022$4,715,000
+42.6%
97,318
+15.6%
0.01%
+44.4%
Q2 2022$3,306,000
+31.5%
84,150
+23.2%
0.01%
+80.0%
Q1 2022$2,514,000
-19.2%
68,287
+0.0%
0.01%
-16.7%
Q4 2021$3,112,000
+29.0%
68,265
+1.1%
0.01%
+20.0%
Q3 2021$2,413,000
+107.8%
67,504
+15.1%
0.01%
+150.0%
Q2 2021$1,161,000
-14.6%
58,646
+0.4%
0.00%
-33.3%
Q1 2021$1,359,000
+11.7%
58,415
-0.3%
0.00%0.0%
Q4 2020$1,217,000
-3.9%
58,586
+0.2%
0.00%0.0%
Q3 2020$1,266,000
+7.9%
58,462
+17.4%
0.00%
-25.0%
Q2 2020$1,173,000
+100.9%
49,777
+0.5%
0.00%
+100.0%
Q1 2020$584,000
+17.0%
49,516
+5.3%
0.00%
+100.0%
Q4 2019$499,000
-5.5%
47,044
+1.5%
0.00%
-50.0%
Q3 2019$528,000
+3.7%
46,359
+2.4%
0.00%0.0%
Q2 2019$509,000
+50.6%
45,283
+8.3%
0.00%
+100.0%
Q1 2019$338,000
+38.5%
41,803
+8.2%
0.00%0.0%
Q4 2018$244,000
-30.3%
38,652
+8.8%
0.00%0.0%
Q3 2018$350,000
+20.7%
35,525
+1.6%
0.00%0.0%
Q2 2018$290,000
+22.4%
34,949
+6.2%
0.00%0.0%
Q1 2018$237,000
-7.1%
32,906
+5.3%
0.00%0.0%
Q4 2017$255,000
-42.6%
31,256
+2.0%
0.00%
-50.0%
Q3 2017$444,000
+30.2%
30,640
+8.7%
0.00%
+100.0%
Q2 2017$341,00028,2000.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders